Literature DB >> 11528165

A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barré syndrome.

H C Diener1, W F Haupt, T M Kloss, F Rosenow, T Philipp, S Koeppen, A Vietorisz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11528165     DOI： 10.1159/000050777

Source DB:  PubMed          Journal:  Eur Neurol        ISSN： 0014-3022            Impact factor:   1.710


× No keyword cloud information.
  16 in total

1.  Pathogenesis and treatment of immune-mediated neuropathies.

Authors:  Helmar C Lehmann; Gerd Meyer Zu Horste; Bernd C Kieseier; Hans-Peter Hartung
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

Review 2.  Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity.

Authors:  Luanna Yang; Eveline Y Wu; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

3.  A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.

Authors:  Khaled Saad; Ismail L Mohamad; Mohamed A Abd El-Hamed; Mostafa S K Tawfeek; Ahmed E Ahmed; Khaled A Abdel Baseer; Ahmed S El-Shemy; Amira A El-Houfey; Diaa M Tamer
Journal:  Ther Adv Neurol Disord       Date:  2016-01       Impact factor: 6.570

4.  Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.

Authors:  Jérôme J Devaux
Journal:  Am J Pathol       Date:  2012-08-10       Impact factor: 4.307

Review 5.  [The significance of intravenous immunoglobulin in treatment of immune-mediated polyneuropathies].

Authors:  M Stangel; H-P Hartung; R Gold; B C Kieseier
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

6.  Selective immune adsorption treatment of severe Guillain Barré syndrome in the intensive care unit.

Authors:  N Galldiks; C Dohmen; M Neveling; G R Fink; W F Haupt
Journal:  Neurocrit Care       Date:  2009-12       Impact factor: 3.210

Review 7.  Advances in the management of Guillain-Barré syndrome.

Authors:  Deborah M Green
Journal:  Curr Neurol Neurosci Rep       Date:  2002-11       Impact factor: 5.081

8.  Inpatient management of guillain-barré syndrome.

Authors:  Matthew Harms
Journal:  Neurohospitalist       Date:  2011-04

Review 9.  Intravenous immunoglobulin for Guillain-Barré syndrome.

Authors:  Richard A C Hughes; Anthony V Swan; Pieter A van Doorn
Journal:  Cochrane Database Syst Rev       Date:  2014-09-19

10.  Predictors for good functional outcome after neurocritical care.

Authors:  Ines C Kiphuth; Peter D Schellinger; Martin Köhrmann; Jürgen Bardutzky; Hannes Lücking; Stephan Kloska; Stefan Schwab; Hagen B Huttner
Journal:  Crit Care       Date:  2010-07-20       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.